cysteine has been researched along with fibrinopeptide a in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biasiutti, FD; Furlan, M; Lämmle, B; Leupin, L | 1 |
| Bauer, KA; Chin, DT; Clyne, LP; Kaczmarek, E; Lee, MH; McDonagh, J; McIntosh, S; Oda, A | 1 |
| Asakura, S; Hirata, H; Matsuda, M; Morita, K; Shirakawa, S; Wada, H; Yamazumi, K; Yoshida, N | 1 |
| Bögli, C; Bouvier, CA; de Moerloose, P; Furlan, M; Hofer, A | 1 |
| Ascari, E; Bottazzi, B; Grignani, G; Mantovani, A; Pacchiarini, L; Pagliarino, M; Ricetti, MM | 1 |
| Barbui, T; Beck, EA; Buelli, M; Finazzi, G; Furlan, M; Reber, P | 1 |
| Deutsch, E; Henschen, A; Kehl, M | 1 |
| Brennan, SO; George, PM; Hammonds, B; Spearing, R | 1 |
| Chalmers, MJ; Ferro, M; Gaskell, SJ; Gielbert, J; Gora, L; Mohammed, S; Smith, DC | 1 |
9 other study(ies) available for cysteine and fibrinopeptide a
| Article | Year |
|---|---|
[Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys].
Topics: Adult; Arginine; Blood Coagulation Disorders; Cysteine; Female; Fibrinogens, Abnormal; Fibrinopeptide A; Humans; Middle Aged; Pedigree; Prothrombin Time; Thrombin | 1991 |
Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
Topics: Amino Acid Sequence; Arginine; Blood Coagulation Disorders; Calcium; Child; Chromatography, High Pressure Liquid; Cysteine; Fibrinogens, Abnormal; Fibrinopeptide A; Fibrinopeptide B; Humans; Macromolecular Substances; Male; Molecular Sequence Data; Platelet Aggregation | 1991 |
A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.
Topics: Amino Acid Sequence; Batroxobin; Blood Coagulation Disorders; Blood Coagulation Tests; Chromatography, High Pressure Liquid; Cysteine; Fibrin; Fibrinogens, Abnormal; Fibrinopeptide A; Fibrinopeptide B; Glycine; Humans; Male; Middle Aged; Molecular Sequence Data; Thrombin | 1991 |
Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia.
Topics: Blood Coagulation Tests; Cysteine; Female; Fibrinogens, Abnormal; Fibrinopeptide A; Fibrinopeptide B; Humans; Middle Aged; Pedigree; Pregnancy; Thrombin | 1990 |
Role of tumor proteinases in tumor cell-induced platelet aggregation.
Topics: Adult; Animals; Cell Communication; Cell Line; Cell Membrane; Cysteine; Endopeptidases; Fibrinopeptide A; Humans; Iodoacetates; Iodoacetic Acid; Mice; Neoplasms, Experimental; Platelet Aggregation; Protease Inhibitors | 1986 |
Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues.
Topics: Amino Acids; Aziridines; Blood Coagulation Disorders; Blood Coagulation Tests; Cysteine; Female; Fibrinogen; Fibrinogens, Abnormal; Fibrinopeptide A; Fibrinopeptide B; Humans; Male; Mercaptoethanol; Methylation; Thrombin | 1985 |
Novel structure elucidation strategy for genetically abnormal fibrinogens with incomplete fibrinopeptide release as applied to fibrinogen Schwarzach.
Topics: Amino Acids; Arginine; Chromatography, High Pressure Liquid; Cysteine; Fibrinogen; Fibrinogens, Abnormal; Fibrinopeptide A; Genetic Variation; Heterozygote; Humans | 1983 |
Electrospray ionisation mass spectrometry facilitates detection of fibrinogen (Bbeta 14 Arg --> Cys) mutation in a family with thrombosis.
Topics: Adult; Amino Acid Substitution; Arginine; Catalysis; Cysteine; Family Health; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Glycoproteins; Heterozygote; Humans; Mass Spectrometry; Molecular Weight; Mutation; Point Mutation; Polymerase Chain Reaction; Sequence Analysis; Thrombin; Thrombosis | 1997 |
A novel tandem quadrupole mass spectrometer allowing gaseous collisional activation and surface induced dissociation.
Topics: Amino Acid Sequence; Angiotensinogen; Bradykinin; Cysteine; Dynorphins; Enkephalin, Leucine; Fibrinopeptide A; Mass Spectrometry; Molecular Sequence Data; Molecular Structure; Peptide Fragments; Reproducibility of Results; Sensitivity and Specificity; Thermodynamics | 2001 |